InMed Pharmaceuticals INM
NASDAQ INM
$1.38 +0.01 (+0.53%)
As of: Sep 30, 2026 · 12:40 PM EDT

InMed Pharmaceuticals Inc. (INM) EBIT Margin (2021 - 2025)

Updated

InMed Pharmaceuticals' EBIT Margin was -256.36% in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 53.60 percentage points from -202.75% a year earlier and down 93.81 percentage points from the prior quarter.

Analysis

InMed Pharmaceuticals Inc. (INM) EBIT Margin (2021 - 2025) Analysis & Trends

On a trailing twelve-month basis, InMed Pharmaceuticals' EBIT Margin was -158.01% through Dec 31, 2025, up 4.81 percentage points year-over-year; for FY2025 (ended Jun 30, 2025), it came in at -136.93%, up 41.34 percentage points from FY2024.

  • EBIT Margin has now increased for three consecutive fiscal years, with a three-year change of +1447.77 percentage points (FY2022 to FY2025).
  • In earlier fiscal years, EBIT Margin was -178.27% in FY2024 (+25.50 pp), -203.77% in FY2023 (+1380.94 pp) and -1584.71% in FY2022.
  • The fiscal Q2 2026 figure marks the lowest quarterly EBIT Margin since fiscal Q1 2024.
  • Compared with a year earlier, EBIT Margin was higher in four of the last eight quarters, with an average year-over-year change of -1.36 percentage points.
  • The best year-over-year quarter for EBIT Margin over five years was fiscal Q4 2023 (a gain of 1245.62 percentage points); the worst was fiscal Q4 2024 (a drop of 137.55 percentage points).
  • Per Business Quant data, INM's EBIT Margin in the three fiscal quarters before Q2 2026 was -162.54% (Q1 2026), -98.85% (Q4 2025) and -151.24% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -256.36%
Sep 30, 2025 -162.54%
Jun 30, 2025 -98.85%
Mar 31, 2025 -151.24%
Dec 31, 2024 -202.75%
Sep 30, 2024 -137.19%
Jun 30, 2024 -158.54%
Mar 31, 2024 -157.28%
Dec 31, 2023 -132.64%
Sep 30, 2023 -296.37%
Jun 30, 2023 -20.99%
Mar 31, 2023 -208.13%
Dec 31, 2022 -471.26%
Sep 30, 2022 -1,114.75%
Jun 30, 2022 -1,266.61%
Mar 31, 2022 -1,143.35%
Dec 31, 2021 -1,626.64%
API Access

InMed Pharmaceuticals Inc. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=INM&period=max&api_key=YOUR_API_KEY